TickerFacts.

Sonoma Pharmaceuticals, Inc. (SNOA): Shareholders' Equity

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2020-03-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$3.10M
As of 2026-03-31
$6.59M
As of 2026-06-30
-27.1%
3-year compound annual growth
-10.4%
5-year compound annual growth
$21.43M2011-03-31: $1.70M2012-03-31: -$868.0K2013-03-31: $4.08M2014-03-31: $12.06M2015-03-31: $12.05M2016-03-31: $10.14M2017-03-31: $21.43M2018-03-31: $15.33M2019-03-31: $10.49M2020-03-31: $5.62M2021-03-31: $5.36M2022-03-31: $8.70M2023-03-31: $7.98M2024-03-31: $6.14M2025-03-31: $4.41M2026-03-31: $3.10M$3.10M
2011-03-31 Shareholders' Equity (USD) 2026-03-31
Period endedShareholders' EquityChange YoYSource filing
2026-03-31$3.10M-29.8%2026-06-16, Balance as of period end
2025-03-31$4.41M-28.1%2026-06-16, Balance as of period end
2024-03-31$6.14M-23.1%2025-06-17, Balance as of period end
2023-03-31$7.98M-8.3%2024-06-17, Balance as of period end
2022-03-31$8.70M+62.2%2023-06-21, Balance as of period end
2021-03-31$5.36M-4.6%2022-07-13, Balance as of period end
2020-03-31$5.62Mn/c2021-07-14, Balance as of period end
2019-03-31$10.49M-31.6%2020-07-10, Balance as of period end
2018-03-31$15.33M-28.5%2019-07-01, Balance as of period end
2017-03-31$21.43M+111.4%2018-06-26, Balance as of period end
2016-03-31$10.14M-15.9%2017-06-28, Balance as of period end
2015-03-31$12.05M-0.1%2016-06-21, Balance as of period end
2014-03-31$12.06M+195.6%2015-06-16, Balance as of period end
2013-03-31$4.08Mn/m2014-06-30, Balance as of period end
2012-03-31-$868.0Kn/m2013-06-25, Balance as of period end
2011-03-31$1.70Mn/a2012-06-21, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$3.10M-29.8%
Spectral AI, Inc. (MDAI)2025-12-31-$5.73Mn/m
Nephros Inc (NEPH)2025-12-31$10.20M+18.8%
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$1.49Mn/m
DarioHealth Corp. (DRIO)2025-12-31$67.92M-5.7%
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$31.22M-21.5%
Profound Medical Corp. (PROF)2025-12-31$66.43M+10.0%
Biotricity Inc. (BTCY)2026-03-31-$34.68Mn/m
Allurion Technologies, Inc. (ALUR)2025-12-31-$77.19Mn/m

Compare SNOA, MDAI, NEPH, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗